Cargando…

AB110. Efficacy and safety of mTOR inhibitor in the treatment of renal cell cancer: a meta-analysis

BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved median progression-free survival (MPFS). We aimed to determine the relative effectiveness of new therapies in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Keke, Yan, Fei, Wang, Fuli, Yuan, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708334/
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s110

Ejemplares similares